Skip to main content

Table 4 Infections requiring antibiotics for patients who discontinued treatment after 6 months of LOT initiation

From: Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study

Variable LOT1 (n = 126) LOT2 (n = 79) LOT3 (n = 38) LOT4 (n = 19)
Abatacept (n = 12) Other bDMARD (n = 114) Abatacept (n = 12) Other bDMARD (n = 67) Abatacept (n = 8) Other bDMARD (n = 30) Abatacept (n = 7) Other bDMARD (n = 12)
Infections (requiring antibiotics)
 Experienced event (%) a 27 (23.7%) a 18 (26.9%) a 13 (43.3%) a 5 (41.7%)
 Discontinued treatment (%) a 27 (23.7%) a 18 (26.9%) 0 (0.0%) 12 (40.0%) a 5 (41.7%)
  1. LOT Line of therapy
  2. aCells suppressed due to small numbers